MedTrace Logo

COVID Booster in Pregnancy and Lactation

NCT05543993 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-12-02

No results posted yet for this study

Summary

This is a prospective longitudinal cohort study to evaluate the impact of COVID-19 vaccination and booster on maternal and infant immunity against COVID-19 variants over time.

Conditions

Interventions

DRUG

Bivalent COVID-19 Booster

Bivalent COVID-19 Booster by Pfizer or Moderna

Sponsors & Collaborators

  • Walter Reed Army Institute of Research (WRAIR)

    collaborator FED

  • Nemours Childrens Health

    collaborator UNKNOWN

  • Thomas Jefferson University

    lead OTHER

Principal Investigators

  • Rupsa C Boelig, MD · Thomas Jefferson University

Eligibility

Min Age
13 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-29
Primary Completion
2024-06-10
Completion
2024-06-10
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05543993 on ClinicalTrials.gov